These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9850604)

  • 41. High throughput assay technologies for ion channel drug discovery.
    Zheng W; Spencer RH; Kiss L
    Assay Drug Dev Technol; 2004 Oct; 2(5):543-52. PubMed ID: 15671652
    [TBL] [Abstract][Full Text] [Related]  

  • 42. How should values of pA2 and affinity constants for pharmacological competitive antagonists be estimated?
    MacKay D
    J Pharm Pharmacol; 1978 May; 30(5):312-3. PubMed ID: 26747
    [No Abstract]   [Full Text] [Related]  

  • 43. [Interaction between the metabolism of drugs: pharmacological aspects].
    von Bahr C; Orrenius S; Sjöqvist F
    Lakartidningen; 1968 Mar; 65():Suppl I:58+. PubMed ID: 5743121
    [No Abstract]   [Full Text] [Related]  

  • 44. Ion channels as pharmacologic receptors: the chirality of drug interactions.
    Triggle DJ
    Chirality; 1996; 8(1):35-8. PubMed ID: 8845280
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Electromagnetic mediated pharmacokinetics in a three-layer diffusional system.
    Seto YJ; Hsieh ST
    Bull Math Biol; 1982; 44(2):215-29. PubMed ID: 7074250
    [No Abstract]   [Full Text] [Related]  

  • 46. Arrestin pathways as drug targets.
    Luttrell LM
    Prog Mol Biol Transl Sci; 2013; 118():469-97. PubMed ID: 23764065
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interactions of drug with the nicotinic acetylcholine receptor and its ionic channel.
    Eldefrawi ME
    Prog Clin Biol Res; 1979; 27():63-71. PubMed ID: 424433
    [No Abstract]   [Full Text] [Related]  

  • 48. Principles in pharmacogenetics.
    Roden DM
    Epilepsia; 2001; 42 Suppl 5():44-8. PubMed ID: 11887967
    [No Abstract]   [Full Text] [Related]  

  • 49. Drug interactions.
    Azarnoff DL; Hurwitz A
    Pharmacol Physicians; 1970 Feb; 4(2):1-7. PubMed ID: 5450332
    [No Abstract]   [Full Text] [Related]  

  • 50. [Problems of drug research].
    Büchi J
    Pharm Weekbl; 1968 Apr; 103(17):429-52. PubMed ID: 4874723
    [No Abstract]   [Full Text] [Related]  

  • 51. [A microcomputer program for the analysis of the drug-receptor bond using radioligands].
    García AJ; Ríus F; López DR; Martos F; de la Cruz JP; Gómez JA; Sánchez de la Cuesta F
    Arch Farmacol Toxicol; 1986 Apr; 12(1):71-82. PubMed ID: 3755582
    [No Abstract]   [Full Text] [Related]  

  • 52. Drug interactions. IV. Interactions among antimicrobial and nonantimicrobial agents.
    Riley HD
    Pediatrics; 1972 Dec; 50(6):954-5. PubMed ID: 4636462
    [No Abstract]   [Full Text] [Related]  

  • 53. [Value and limitations of pharmacokinetics].
    Bogaert M
    Verh K Acad Geneeskd Belg; 1986; 48(4):221-4. PubMed ID: 3788268
    [No Abstract]   [Full Text] [Related]  

  • 54. Some principles of medication in geriatrics.
    Freeman JT
    J Am Geriatr Soc; 1974 Jul; 22(7):289-95. PubMed ID: 4841254
    [No Abstract]   [Full Text] [Related]  

  • 55. Novel flow injection methods for drug-receptor interaction studies, based on probing cell metabolism.
    Lähdesmäki I; Ruzicka J; Ivaska A
    Analyst; 2000 Oct; 125(10):1889-95. PubMed ID: 11070559
    [No Abstract]   [Full Text] [Related]  

  • 56. The measurement of efficacy in the drug discovery agonist selection process.
    Kenakin T
    J Pharmacol Toxicol Methods; 1999 Dec; 42(4):177-87. PubMed ID: 11033433
    [No Abstract]   [Full Text] [Related]  

  • 57. Pharmacogenetic variability in brain and muscle.
    Kalow W
    J Pharm Pharmacol; 1994 May; 46 Suppl 1():425-32. PubMed ID: 8064561
    [No Abstract]   [Full Text] [Related]  

  • 58. Developmental pharmacology: overview.
    Fouts JR
    Environ Health Perspect; 1976 Dec; 18():3-4. PubMed ID: 1030400
    [No Abstract]   [Full Text] [Related]  

  • 59. [The biochemistry of toxic effects].
    Jacyszyn K
    Folia Med Cracov; 1987; 28(1-2):47-60. PubMed ID: 3623325
    [No Abstract]   [Full Text] [Related]  

  • 60. Non-linear coupling between receptor occupancy and biologic effect as a requirement for a higher drug efficacy.
    Swillens S; Dumont JE
    Mol Cell Endocrinol; 1980 Dec; 20(3):233-42. PubMed ID: 6258999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.